Evidence map›Paper›PMID 40202990›Full record

ArticlePloS one2025

Metabolomics analysis of five cultivars of Sorghum bicolor reveals the contribution of flavonoid pathway to tannin content.

Xianlin Ni, Wenjing Long, Lijuan Gong, Jia Zheng, Yanghua Li, Zhenhui Kang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xianlin NiRice and Sorghum Research Institute, Sichuan Academy of Agricultural Sciences, Deyang, China.
Wenjing LongRice and Sorghum Research Institute, Sichuan Academy of Agricultural Sciences, Deyang, China.ORCID 0000-0002-9637-6007
Lijuan GongCollege of Biological Engineering, Sichuan University of Science & Engineering, Yibin, China.
Jia ZhengWuliangye Yibin Co., Ltd., Yibin, China.
Yanghua LiWuliangye Yibin Co., Ltd., Yibin, China.
Zhenhui KangCollege of Biological Engineering, Sichuan University of Science & Engineering, Yibin, China.ORCID 0000-0002-5915-8617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to utilize metabolomics to elucidate the key metabolites and metabolic pathways contributing to the quality differences among the grains of 'hongyingzi' (hyz) sorghum and four other varieties naming 'jinuoliang' (Jinl), 'jinnuoliang' (Jinnl), 'lunuohong' (lnh) and 'liaoza 19' (lz19). By analyzing the metabolomics data of the five sorghum varieties, we identified a total of 384 differentially accumulated metabolites (DAMs). Among these, flavonoids, phenolic acids and lipid compounds were the most abundant, exhibiting varying degrees of upregulation and downregulation. Compared to the four cultivars, the hyz sorghum differently exhibited 78, 40, 59 and 63 flavonoids; 29, 54, 30 and 30 phenolic acids; and 9, 27, 26 and 20 lipids, respectively. Multiple comparisons among the five sorghum varieties also identified 38 common DAMs, and the flavonoid pathway is particularly significant in KEGG enrichment. Additionally, as a high tannin content variety, correlation analysis revealed in sorghum that ellagic acid-4-O-glucoside plays a central role in tannin synthesis. These findings would highlight significant differences in the metabolomic profiles between hyz and the control varieties, providing valuable insights for the exploration of key genes involved in flavonoid metabolism and biosynthesis pathways in sorghum seeds.

Indexed as

FlavonoidsMetabolomicsSorghumTanninsHydroxybenzoatesMetabolic Networks and PathwaysMetabolomeFlavonoidsHydroxybenzoatesphenolic acidTannins

Identifiers

PMID40202990
PMCPMC11981146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.